{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:08:19Z","timestamp":1791900499118,"version":"4.3.4"},"reference-count":75,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1016\/j.critrevonc.2004.12.004","type":"journal-article","created":{"date-parts":[[2005,1,29]],"date-time":"2005-01-29T08:49:10Z","timestamp":1106988550000},"page":"107-116","source":"Crossref","is-referenced-by-count":90,"title":["Multi-dysfunctional pathophysiology in ITP"],"prefix":"10.1016","volume":"54","author":[{"given":"Bin","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren Chi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong Chao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2004.12.004_bib1","first-page":"18","article-title":"Pathogenesis and management of idiopathic thrombocytopenic purpura: an update","volume":"71","author":"Yang","year":"2000","journal-title":"Int J Hematol"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib2","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1056\/NEJMra010501","article-title":"Immune thrombocytopenic purpura","volume":"346","author":"Cines","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1054\/blre.2001.0172","article-title":"Immune pathophysiology of autoimmune thrombocytopenic purpura","volume":"16","author":"Semple","year":"2002","journal-title":"Blood Rev"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib4","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1053\/tmrv.2003.50004","article-title":"Cellular immune mechanisms in autoimmune thrombocytopenic purpura: an update","volume":"17","author":"Coopamah","year":"2003","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib5","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1182\/blood.V77.10.2207.2207","article-title":"Autoantibodies to the presumptive cytoplasmic domain of platelet glycoprotein IIIa in patients with chronic immune thrombocytopenic purpura","volume":"77","author":"Fujisawa","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib6","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1172\/JCI4238","article-title":"Autoreactive T cells to platelet GPIIb-IIIa in immune thrombocytopenic purpura. Role in production of anti-platelet autoantibody","volume":"102","author":"Kuwana","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib7","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1096\/fasebj.12.13.1255","article-title":"Molecular mimicry and immune-mediated diseases","volume":"12","author":"Oldstone","year":"1998","journal-title":"FASEB J"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib8","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1046\/j.1365-2141.1996.d01-1872.x","article-title":"Characterization of platelet-reactive antibodies in children with varicella-associated acute immune thrombocytopenic purpura (ITP)","volume":"95","author":"Wright","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib9","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1182\/blood.V98.1.130","article-title":"Immunodominant epitopes on glycoprotein IIb-IIIa recognized by autoreactive T cells in patients with immune thrombocytopenic purpura","volume":"98","author":"Kuwana","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib10","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1182\/blood.V68.2.488.488","article-title":"Determination of platelet antigens and glycoproteins in the human fetus","volume":"68","author":"Gruel","year":"1986","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib11","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1182\/blood.V88.6.2144.bloodjournal8862144","article-title":"Presence in peripheral blood of healthy individuals of autoreactive T cells to a membrane antigen present on bone marrow-derived cells","volume":"88","author":"Filion","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1600-065X.1991.tb00598.x","article-title":"Peripheral tolerance in transgenic mice: tolerance to class II MHC and non-MHC transgene antigens","volume":"122","author":"Lo","year":"1991","journal-title":"Immunol Rev"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib13","first-page":"111","article-title":"CD4+CD25+ T cells as key regulators of immune responses","volume":"13","author":"Dubois","year":"2003","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib14","doi-asserted-by":"crossref","first-page":"6323","DOI":"10.4049\/jimmunol.171.12.6323","article-title":"The regulatory T cell family: distinct subsets and their interrelations","volume":"171","author":"Jonuleit","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib15","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1182\/blood.V100.4.1388.h81602001388_1388_1398","article-title":"Genetic analysis of autoantibodies in idiopathic thrombocytopenic purpura reveals evidence of clonal expansion and somatic mutation","volume":"100","author":"Jessica","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib16","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/nri856","article-title":"Roles of Fc receptors in autoimmunity","volume":"2","author":"Takai","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib17","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.4049\/jimmunol.157.7.2924","article-title":"B7 costimulation and autoantigen specificity enable B cells to activate autoreactive T cells","volume":"157","author":"Roth","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib18","series-title":"Fundamental immunology","first-page":"1089","article-title":"Organ-specific autoimmunity","author":"Shevach","year":"1999"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib19","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1097\/00043426-200312001-00012","article-title":"Mechanisms of action of therapeutics in idiopathic thrombocytopenic purpura","volume":"25","author":"Cines","year":"2003","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib20","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.4049\/jimmunol.168.7.3675","article-title":"Spleen is a primary site for activation of platelet-reactive T and B cells in patients with immune thrombocytopenic purpura","volume":"168","author":"Kuwana","year":"2002","journal-title":"J Immunol"},{"issue":"Suppl. 2","key":"10.1016\/j.critrevonc.2004.12.004_bib21","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1423-0410.1998.tb05436.x","article-title":"Immune thrombocytopenic purpura ITP","volume":"74","author":"Imbach","year":"1998","journal-title":"Vox Sang"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib22","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1182\/blood.V78.10.2619.2619","article-title":"Increased anti-platelet T helper lymphocyte reactivity in patients with autoimmune thrombocytopenia","volume":"78","author":"Semple","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib23","first-page":"474","article-title":"Expression of costimulatory molecules on peripheral blood lymphocytes of patients with idiopathic thrombocytopenic purpura","volume":"24","author":"Zhao","year":"2003","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib24","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1182\/blood-2002-06-1666","article-title":"Effects of B7-blocking agent and\/or CsA on induction of platelet-specific T-cell anergy in chronic autoimmune thrombocytopenic purpura","volume":"101","author":"Peng","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2776(08)60865-2","article-title":"CD40-CD40 ligand: a multifunctional receptor-ligand pair","volume":"61","author":"Van","year":"1996","journal-title":"Adv Immunol"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib26","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-3476(97)70123-9","article-title":"Clinical spectrum of X-linked hyper-IgM syndrome","volume":"131","author":"Levy","year":"1997","journal-title":"J Pediatr"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib27","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1146\/annurev.immunol.16.1.111","article-title":"CD40 and CD154 in cell-mediated immunity","volume":"16","author":"Grewal","year":"1998","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib28","first-page":"343","article-title":"CD40-CD154 interaction in experimental and human disease","volume":"3","author":"Biancone","year":"1999","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib29","first-page":"2367","article-title":"Platelet-associated CD154 in immune thrombocytopenic purpura","volume":"07","author":"Solanilla","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib30","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/35393","article-title":"CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells","volume":"391","author":"Henn","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib31","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1080\/09537100020031207","article-title":"Platelet CD40 ligand (CD40L) subcellular localization, regulation of expression, and inhibition by clopidogrel","volume":"12","author":"Hermann","year":"2001","journal-title":"Platelets"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib32","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/0891693031000153803","article-title":"Induction of T cell tolerance in a patient with idiopathic thrombocytopenic purpura by single injection of humanized monoclonal antibody to CD40 ligand","volume":"36","author":"Nomura","year":"2003","journal-title":"Autoimmunity"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib33","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1182\/blood-2002-07-2157","article-title":"Suppression of autoreactive T cell response to glycoprotein IIb\/IIIa by blockade of CD40\/CD154 interaction: implications for treatment of immune thrombocytopenic purpura","volume":"101","author":"Kuwana","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib34","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/0891693031000153803","article-title":"Induction of T cell tolerance in a patient with idiopathic thrombocytopenic purpura by single injection of humanized monoclonal antibody to CD40 ligand","volume":"36","author":"Nomura","year":"2003","journal-title":"Autoimmunity"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib35","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1182\/blood.V89.8.2871","article-title":"Deficiency of the Fas apoptosis pathway without Fas gene mutations in pediatric patients with autoimmunity\/lymphoproliferation","volume":"89","author":"Dianzani","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib36","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1006\/clim.2001.5017","article-title":"Defective apoptosis in lymphocytes and the role of IL-2 in autoimmune hematologic cytopenias","volume":"99","author":"Shenoy","year":"2001","journal-title":"Clin Immunol"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib37","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1034\/j.1600-0609.2000.9o096.x","article-title":"Plasma-soluble Fas (APO-1, CD95) and soluble Fas ligand in immune thrombocytopenic purpura","volume":"64","author":"Yoshimura","year":"2000","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib38","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0037-1963(00)90112-4","article-title":"The spleen and splenectomy in immune (idiopathic) thrombocytopenic purpura","volume":"37","author":"Sandler","year":"2000","journal-title":"Semin Hematol"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib39","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1074-7613(03)00080-3","article-title":"Colony-stimulating factor-1-dependent macrophages are responsible for IVIG protection in antibody-induced autoimmune disease","volume":"18","author":"Bruhns","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib40","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1365-2141.2003.04033.x","article-title":"Fcy recptor Iia and IIIa polymorphisms in childhood immune thrombocytopenic purpura","volume":"120","author":"Carcao","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib41","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1067\/mai.2003.1380","article-title":"IgG Fc receptor polymorphisms in human disease: implications for intravenous immunoglobulin therapy","volume":"111","author":"Bryce","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib42","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0037-1963(00)90104-5","article-title":"Fc receptor blockade and immune thrombocytopenic purpura","volume":"37","author":"Bussel","year":"2000","journal-title":"Semin Hematol"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib43","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.immunol.20.092501.134942","article-title":"KIR: diverse, rapidly evolving receptors of innate and adaptive immunity","volume":"20","author":"Vilches","year":"2002","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib44","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/nm921","article-title":"T-cell-mediated cytotoxicity toward platelet in chronic idiopathic thrombocytopenic purpura","volume":"9","author":"Olsson","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib45","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S1473-0502(03)00041-7","article-title":"T cell and cytokine abnormalities in patients with autoimmune thrombocytopenic purpura","volume":"28","author":"Semple","year":"2003","journal-title":"Transfus Apheresis Sci"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib46","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1651-2227.1998.tb01237.x","article-title":"Cytokines in idiopathic thrombocytopenic purpura (ITP)","volume":"424","author":"Andersson","year":"1998","journal-title":"Acta Paediatr Suppl"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib47","first-page":"662","article-title":"Interleukin-18 and its related cytokines in plasma of patients with idiopathic thrombocytopenic purpura","volume":"11","author":"Zhang","year":"2003","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib48","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s002770000177","article-title":"A transforming growth factor-beta1-mediated bystander immune suppression could be associated with remission of chronic idiopathic thrombocytopenic purpura","volume":"79","author":"Andersson","year":"2000","journal-title":"Ann Hematol"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib49","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/S0198-8859(01)00348-2","article-title":"Functional properties of lymphocytes in idiopathic thrombocytopenic purpura","volume":"62","author":"Webber","year":"2001","journal-title":"Hum Immunol"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib50","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1034\/j.1600-0609.2003.00138.x","article-title":"High Th1\/Th2 ratio in patients with chronic idiopathic thrombocytopenic purpura","volume":"71","author":"Ogawara","year":"2003","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib51","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1182\/blood.V87.10.4245.bloodjournal87104245","article-title":"Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: relationship to platelet phenotype and anti-platelet T-cell reactivity","volume":"87","author":"Semple","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib52","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1182\/blood-2003-07-2268","article-title":"Adult chronic idiopathic thrombocytopenic purpura (ITP) is the manifestation of a type-1 polarized immune response","volume":"103","author":"Panitsas","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib53","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1089\/107999001750133159","article-title":"Dexamethasone promotes type 2 cytokine production primarily through inhibition of type 1 cytokines","volume":"21","author":"Agarwal","year":"2001","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib54","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1182\/blood.V100.5.1774.h81702001774_1774_1779","article-title":"Expression patterns of Th1 and Th2 cytokine genes in childhood idiopathic thrombocytopenic purpura (ITP) at presentation and their modulation by intravenous immunoglobulin G (IVIg) treatment: their role in prognosis","volume":"100","author":"Mouzaki","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib55","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1126\/science.2113314","article-title":"A cell culture model for T-lymphocyte clonal anergy","volume":"248","author":"Schwartz","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib56","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/intimm\/3.3.229","article-title":"IL-4 and IL-2 upregulate the expression of antigen B7, the B cell counterstructure to T-cell CD28: an amplification mechanism for T\u2013B cell interactions","volume":"3","author":"Valle","year":"1991","journal-title":"Int Immunol"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib57","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/346844a0","article-title":"Loss pancreatic islet tolerance induced by beta-cell expression of interferon-gamma","volume":"346","author":"Sarvetnick","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib58","doi-asserted-by":"crossref","first-page":"432","DOI":"10.4049\/jimmunol.144.2.432","article-title":"Transforming growth factor beta 1 has differential effects on B cell proliferation and activation antigen expression","volume":"144","author":"Cross","year":"1990","journal-title":"J Immunol"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib59","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S1471-4906(01)01944-5","article-title":"In vivo models of dominant T cell tolerance: where do we stand today?","volume":"22","author":"Coutinho","year":"2001","journal-title":"Trends Immunol"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib60","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.4049\/jimmunol.161.4.1772","article-title":"TGF-beta inhibits IL-12-induced activation of Jak-STAT pathway in T-lymphocytes","volume":"161","author":"Bright","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib61","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1084\/jem.175.3.671","article-title":"Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A","volume":"175","author":"Defrance","year":"1992","journal-title":"J Exp Med"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib62","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.4049\/jimmunol.147.11.3815","article-title":"IL-10 inhibits cytokine production by activated macrophages","volume":"147","author":"Fiorentino","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib63","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1084\/jem.177.4.1205","article-title":"Interleukin 10 protects mice from lethal endotoxemia","volume":"177","author":"Howard","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib64","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1182\/blood.V81.5.1251.1251","article-title":"Increased macrophage colony-stimulating factor levels in immune thrombocytopenic purpura","volume":"81","author":"Zeigler","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib65","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0925-5710(96)00447-1","article-title":"High-dose intravenous gamma globulin reduces macrophage colony-stimulating factor levels in idiopathic thrombocytopenic purpura","volume":"63","author":"Nomura","year":"1996","journal-title":"Int J Hematol"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib66","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/08916939609001950","article-title":"Effects of interferon-alpha therapy on immune parameters in immune thrombocytopenic purpura","volume":"24","author":"Crossley","year":"1996","journal-title":"Autoimmunity"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib67","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1365-2141.2004.04804.x","article-title":"Intravenous (IV) anti-D and IV immunoglobulin achieve acute platelet increases by different mechanisms: modulation of cytokine and platelet responses to IV anti-D by FcgammaRIIa and FcgammaRIIIa polymorphisms","volume":"124","author":"Cooper","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib68","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/sj.thj.6200106","article-title":"Release of cytokines and soluble cytokine receptors after intravenous anti-D treatment in children with chronic thrombocytopenic purpura","volume":"2","author":"Iwona","year":"2001","journal-title":"Hematol J"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib69","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1046\/j.1365-2141.1999.01218.x","article-title":"A prospective study of protein-specific assays used to investigate idiopathic thrombocytopenic purpura","volume":"104","author":"Warner","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib70","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1182\/blood.V88.1.194.194","article-title":"Prospective evaluation of the clinical usefulness of an antigen-specific assay (MAIPA) in idiopathic thrombocytopenic purpura and other immune thrombocytopenias","volume":"88","author":"Brighton","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib71","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1600-0609.1996.tb00298.x","article-title":"Detection of platelet antibodies in chronic idiopathic thrombocytopenic purpura (ITP). A comparative study using flow cytometry, a whole platelet ELISA, and an antigen capture ELISA","volume":"56","author":"Stockelberg","year":"1996","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib72","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1182\/blood.V87.10.4245.bloodjournal87104245","article-title":"Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: relationship to platelet phenotype and anti-platelet T-cell reactivity","volume":"87","author":"Semple","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib73","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1182\/blood.V93.6.1951.406a33_1951_1958","article-title":"Influence of monoclonal anti-platelet glycoprotein antibodies on in vitro human megakaryocyte colony formation and proplatelet formation","volume":"93","author":"Takahashi","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib74","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1182\/blood-2002-05-1475","article-title":"Immune thrombocytopenic purpura plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro","volume":"102","author":"Chang","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2004.12.004_bib75","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1182\/blood-2003-08-2672","article-title":"Suppression of in vitro megakaryocyte production by anti-platelet autoantibodies from adult patients with chronic ITP","volume":"103","author":"McMillan","year":"2004","journal-title":"Blood"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842804002239?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842804002239?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T21:14:59Z","timestamp":1682975699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842804002239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":75,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["S1040842804002239"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2004.12.004","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2005,5]]}}}